Physiologically Inspired Mucin Coated Escherichia coli Nissle 1917 Enhances Biotherapy by Regulating the Pathological Microenvironment to Improve Intestinal Colonization
Top Cited Papers
- 1 March 2022
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 16 (3) , 4041-4058
Abstract
The delivery of probiotics to the microbiota is a promising method to prevent and treat diseases. However, oral probiotics will suffer from gastrointestinal insults, especially the pathological microenvironment of inflammatory diseases such as reactive oxygen species (ROS) and the exhausted mucus layer, which can limit their survival and colonization in the intestinal tract. Inspired by the fact that probiotics colonized and grew in the mucus layer under physiological conditions, we developed a strategy for a super probiotic ([email protected]2+@Mucin) coated with tannic acid and mucin via layer-by-layer technology. We demonstrated that mucin endows probiotics with superior resistance to the harsh environment of the gastrointestinal tract and with strong adhesiveness to the intestine through its interaction with mucus, which enhanced colonization and growth of probiotics in the mucus layer without removing the coating. Moreover, [email protected]2+@Mucin can distinctly down-regulate inflammation with ROS scavenging and reduce the side effects of bacterial translocation in inflammatory bowel diseases, increasing the abundance and diversity of the gut microflora. We envision that it is a powerful platform to improve the colonization of probiotics by regulating the pathological microenvironment, which is expected to provide an important perspective for applying the intestinal colonization of probiotics to treat a variety of diseases.Keywords
Funding Information
- China Postdoctoral Science Foundation (2020M254785, BX20200309)
- National Natural Science Foundation of China (21904119, 31900991, 81874304, 82073395, U2004197)
- Henan Province (19HASTIT006, 21HASTIT043)
This publication has 63 references indexed in Scilit:
- ROS in gastrointestinal inflammation: Rescue Or Sabotage?British Journal of Pharmacology, 2016
- Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrierScientific Reports, 2015
- Gastrointestinal Microbiota–Mediated Control of Enteric PathogensAnnual Review of Genetics, 2014
- Intestinal dysbacteriosis contributes to decreased intestinal mucosal barrier function and increased bacterial translocationLetters in Applied Microbiology, 2013
- Probiotic Bacteria Reduce Salmonella Typhimurium Intestinal Colonization by Competing for IronCell Host & Microbe, 2013
- An update on the use and investigation of probiotics in health and diseaseGut, 2013
- Escherichia coli Nissle 1917 (Mutaflor): New Insights into an Old Probiotic BacteriumDigestive Diseases, 2011
- Modulation of natural immunity in the gut by Escherichia coli strain Nissle 1917Nutrition Reviews, 2010
- Mucin structure, aggregation, physiological functions and biomedical applicationsCurrent Opinion in Colloid & Interface Science, 2006
- ANTIOXIDANT PROTECTION: A FUNCTION OF TRACHEOBRONCHIAL AND GASTROINTESTINAL MUCUSThe Lancet, 1984